CURRENT MEDICAL IMAGING REVIEWS, vol.13, no.4, pp.431-437, 2017 (SCI-Expanded)
Objectives: The purpose of the study is predicting the sites of the recurrence with PET/CT by serum CA-125 level and detecting the cut-off value of CA-125 for metastatic ovarian cancer (OC) in comparison with Fluorine-18 FDG PET/CT.